Hansa Biopharma AB (24H.F) Q3 2024 Earnings

18JulConfirmed
Q3 2024
-0.28
-0.27
-0.25
-0.24

Details

Expected EPS
-0.23948282718587702
Actual EPS
-0.2842406523
Surprise EPS
-0.04
Surprise Percent
+18.69%

Description

Hansa Biopharma AB (24H.F) has reported earnings of -0.2842406523 per share for Q3 2024.

0 Comments

Share your thoughts